These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20187243)

  • 21. [A case-control study on risk factors in etiology of Parkinson's disease].
    Yang J; Wu Z; Lou X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Feb; 15(1):6-9. PubMed ID: 8082143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease: 10 years of progress, 1997-2007.
    Fahn S
    Mov Disord; 2010; 25 Suppl 1():S2-14. PubMed ID: 20187239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nongenetic causes of Parkinson's disease.
    Chade AR; Kasten M; Tanner CM
    J Neural Transm Suppl; 2006; (70):147-51. PubMed ID: 17017522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroprotection in Parkinson's disease: clinical trials.
    Stocchi F; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S87-97; discussion S97-9. PubMed ID: 12666101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkinson's at risk syndrome: can Parkinson's disease be predicted?
    Stern MB; Siderowf A
    Mov Disord; 2010; 25 Suppl 1():S89-93. PubMed ID: 20187248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene-environment interactions in sporadic Parkinson's disease.
    Benmoyal-Segal L; Soreq H
    J Neurochem; 2006 Jun; 97(6):1740-55. PubMed ID: 16805780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uric acid in Parkinson's disease.
    Schlesinger I; Schlesinger N
    Mov Disord; 2008 Sep; 23(12):1653-7. PubMed ID: 18618666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update in the epidemiology of Parkinson's disease.
    Elbaz A; Moisan F
    Curr Opin Neurol; 2008 Aug; 21(4):454-60. PubMed ID: 18607207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson's disease.
    Deng Y; Newman B; Dunne MP; Silburn PA; Mellick GD
    Neurosci Lett; 2004 Aug; 366(3):326-31. PubMed ID: 15288444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between environmental factors and different Parkinson's disease subtypes in Greece: Data analysis of the Hellenic Biobank of Parkinson's disease.
    Angelopoulou E; Bozi M; Simitsi AM; Koros C; Antonelou R; Papagiannakis N; Maniati M; Poula D; Stamelou M; Vassilatis DK; Michalopoulos I; Geronikolou S; Scarmeas N; Stefanis L
    Parkinsonism Relat Disord; 2019 Oct; 67():105-112. PubMed ID: 31494049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.
    Seidler A; Hellenbrand W; Robra BP; Vieregge P; Nischan P; Joerg J; Oertel WH; Ulm G; Schneider E
    Neurology; 1996 May; 46(5):1275-84. PubMed ID: 8628466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
    Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
    J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of early life environmental risk factors in Parkinson disease: what is the evidence?
    Logroscino G
    Environ Health Perspect; 2005 Sep; 113(9):1234-8. PubMed ID: 16140634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etiology of Parkinson's disease.
    Huang Z; de la Fuente-Fernández R; Stoessl AJ
    Can J Neurol Sci; 2003 Mar; 30 Suppl 1():S10-8. PubMed ID: 12691472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson disease and Alzheimer disease: environmental risk factors.
    Campdelacreu J
    Neurologia; 2014; 29(9):541-9. PubMed ID: 22703631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The epidemiology of Parkinson's disease: risk factors and prevention.
    Ascherio A; Schwarzschild MA
    Lancet Neurol; 2016 Nov; 15(12):1257-1272. PubMed ID: 27751556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of Parkinson's disease.
    Elbaz A; Carcaillon L; Kab S; Moisan F
    Rev Neurol (Paris); 2016 Jan; 172(1):14-26. PubMed ID: 26718594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Environmental toxins and Parkinson's disease.
    Goldman SM
    Annu Rev Pharmacol Toxicol; 2014; 54():141-64. PubMed ID: 24050700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene-environment interactions in Parkinson's disease: the importance of animal modeling.
    Horowitz MP; Greenamyre JT
    Clin Pharmacol Ther; 2010 Oct; 88(4):467-74. PubMed ID: 20811350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut feelings about smoking and coffee in Parkinson's disease.
    Derkinderen P; Shannon KM; Brundin P
    Mov Disord; 2014 Jul; 29(8):976-9. PubMed ID: 24753353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.